Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Solid Lipid Nanoparticles: Production, Characterization And Applications.

W. Mehnert, K. Mäder
Published 2001 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Solid lipid nanoparticles (SLN) have attracted increasing attention during recent years. This paper presents an overview about the selection of the ingredients, different ways of SLN production and SLN applications. Aspects of SLN stability and possibilities of SLN stabilization by lyophilization and spray drying are discussed. Special attention is paid to the relation between drug incorporation and the complexity of SLN dispersions, which includes the presence of alternative colloidal structures (liposomes, micelles, drug nanosuspensions, mixed micelles, liquid crystals) and the physical state of the lipid (supercooled melts, different lipid modifications). Appropriate analytical methods are needed for the characterization of SLN. The use of several analytical techniques is a necessity. Alternative structures and dynamic phenomena on the molecular level have to be considered. Aspects of SLN administration and the in vivo fate of the carrier are discussed.
This paper references
Drug-loaded nanoparticles : preparation methods and drug targeting issues
E. Allémann (1993)
10.1177/0148607181005003230
Invited Review: Development of Fat Emulsions
A. Wretlind (1981)
10.1016/0005-2736(85)90069-0
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents.
T. Madden (1985)
10.1021/JP9912612
Observation of Size-Dependent Melting in Lipid Nanoparticles
T. Unruh (1999)
Stabilization of dry liposomes by carbohydrates.
L. Crowe (1992)
10.1016/S0378-5173(99)00431-7
Influence of spin probe structure on its distribution in SLN dispersions.
P. Ahlin (2000)
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
S. Huang (1992)
10.1016/0169-409X(90)90016-L
Parenteral emulsions for drug delivery
L. Collins-Gold (1990)
10.1111/j.1365-2710.1976.tb00045.x
The emulsion–obsolete dosage form or novel drug delivery system and therapeutic agent?
S. Davis (1976)
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1016/0378-5173(94)90466-9
Incorporation in lipospheres of [d-Trp-6]LHRH
S. Morel (1994)
10.1016/S0378-5173(98)00236-1
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
10.1213/00000539-197705000-00020
Thrombophlebitis After Intravenous Diazepam—Can It Be Prevented?
C. Graham (1977)
10.1016/0005-2736(91)90337-8
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.
J. Senior (1991)
10.1016/0378-5173(90)90074-E
The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure☆
M. J. Pikal (1990)
10.1016/0014-5793(77)80633-9
The polar interactions between pancreatic lipase, colipase and the triglyceride substrate
B. Borgström (1977)
Albumin adsorption on stealth and non-stealth solid lipid nanoparticles
R. Cavalli (1999)
10.1016/0960-0760(90)90445-Q
Pharmacokinetics and endocrine effects of slow release formulations of LHRH analogues
J. Sandow (1990)
10.1007/978-1-4684-7908-9_7
Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration.
H. Hauser (1988)
非経口的栄養剤のための脂肪性エマルジョン III 低電解質負荷非経口的栄養剤のためのリポフンジンMCT/LCT法について
H. MuellerR (1994)
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
R. Mueller (1995)
10.1016/0378-5173(94)00339-7
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair
R. Cavalli (1995)
10.1016/s0021-9258(19)68359-6
Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
F. Martín (1982)
10.1016/0003-9861(85)90498-9
Preservation of freeze-dried liposomes by trehalose.
L. Crowe (1985)
The use of oil-in-water emulsions as a vehicle for parenteral drug administration.
R. Prankerd (1990)
Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters
R. Cavalli (1992)
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
10.1111/j.1749-6632.1987.tb45793.x
Lipid Emulsions as Drug Delivery Systems
S. Davis (1987)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)
Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions
P. Ahlin (1998)
10.1002/JPS.2600790307
Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
S. Venkataram (1990)
10.1016/S0378-5173(99)00066-6
Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins
R. Cavalli (1999)
10.1016/S0378-5173(99)00428-7
Investigation on the viscoelastic properties of lipid based colloidal drug carriers.
A. Lippacher (2000)
Effects of some experimental factors on the production process of solid lipid nanoparticles
R. Cavalli (1996)
10.3109/02652048409031539
Lyophilized liposomes: a new method for long-term vesicular storage.
P. Shulkin (1984)
10.1016/S0001-8686(98)00063-3
Structure, dynamics and transport properties of microemulsions
S. P. Moulik (1998)
10.1016/S0939-6411(98)00023-X
Transformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles - physico-chemical characterization and influence on drug permeation through excised human stratum corneum.
I. Stoye (1998)
10.1016/S0939-6411(97)00107-0
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
S. Morel (1998)
10.1093/AJHP/49.11.2749
Fat emulsion particle-size distribution in total nutrient admixtures.
R. Mehta (1992)
10.1016/S0168-3659(97)01653-2
Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes
R. Mueller (1997)
10.1016/0378-5173(94)00347-8
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix
K. Westesen (1995)
Timolol in lipospheres.
M. Gasco (1992)
10.1016/0378-5173(86)90134-1
Physostigmine emulsion: a new injectable controlled release delivery system
S. Benita (1986)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
10.3109/03639049509048106
Application of an Original process for Obtaining Colloidal Dispersions of Some Coating Polymers. Preparation, Characterization, Industrial Scale-Up
A. Labouret (1995)
SOLID LIPID NANOPARTICLES : PHAGOCYTIC UPTAKE, IN VITRO CYTOTOXICITY AND IN VITRO BIODEGRADATION : 1ST COMMUNICATION
R. H. Muller (1999)
10.1007/s002800050588
Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors
E. P. Sipos (1997)
10.1016/S0939-6411(98)00074-5
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
C. Freitas (1999)
10.1016/S0378-5173(97)00311-6
Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique
R. Mueller (1998)
10.1016/0378-5173(86)90081-5
Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration
A. Smith (1986)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/S0928-0987(99)00071-8
Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect.
M. Jumaa (2000)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1111/j.2042-7158.1986.tb03104.x
Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits
S. Benita (1986)
10.1016/0378-5173(95)00098-4
Long acting injectable oxytetracycline-liposphere formulations
A. Domb (1995)
10.1016/0168-3659(94)90253-4
Phase transition temperature reduction and glass formation in dehydroprotected lyophilized liposomes
W. C. Mobley (1994)
10.2165/00003088-199223040-00004
Liposomal and Lipid Formulations of Amphotericin B
R. Janknegt (1992)
Freeze-drying of emulsions--influence of congealing on granulometry research of a cryoprotective agent.
Y. Bensouda (1989)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
Liposomes as targetable drug carriers.
V. Torchilin (1985)
The theory of high-pressure homogenization
S. Jahnke (2001)
Electron diffraction of solid lipid nanoparticles loaded with aciclovir
G. Lukowski (1997)
10.1016/0005-2736(86)90411-6
Prevention of fusion and leakage in freeze-dried liposomes by carbohydrates
L. Crowe (1986)
10.1016/0378-5173(92)90303-J
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate
B. Sjoestroem (1992)
Characterization of macro molecules, colloids and particles by field-flow fractionation=Characterisierung von Makromolekülen, Kolloiden und Partikeln mit der Field-Flow Fractionation
Stephan Anger (2000)
10.1093/AJHP/31.2.149
Interactions between drugs and plastic intravenous fluid bags. II. Leaching of chemicals from bags containing various solvent media.
P. Moorhatch (1974)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/0378-5173(94)90213-5
Fat emulsions for parenteral nutrition. III: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load
R. H. Müller (1994)
10.1016/0165-6147(94)90314-X
Long-circulating (sterically stabilized) liposomes for targeted drug delivery.
T. Allen (1994)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
10.3109/10611869609015973
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
R. Mueller (1996)
10.3109/03639049109043831
Effect of sugars on freeze-thaw and lyophilization of liposomes
S. Vemuri (1991)
10.1016/0378-5173(93)90237-A
Positively charged submicron emulsions — a new type of colloidal drug carrier
E. Elbaz (1993)
10.1016/S0378-5173(99)00413-5
Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
C. A. S. Maia (2000)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
10.1016/S0378-5173(99)00424-X
Influence of different parameters on reconstitution of lyophilized SLN.
E. Zimmermann (2000)
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
A. Gabizon (1994)
Controlled drug delivery with nanoparticles : current possibilities and future trends
P. Couvreur (1995)
10.1016/S0378-5173(96)04731-X
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
R. Mueller (1996)
10.1016/S0168-3659(99)00007-3
Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.
S. Yang (1999)
10.1016/0024-3205(87)90138-X
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
L. Illum (1987)
10.1006/PHRS.1999.0509
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
G. Zara (1999)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1016/0005-2736(86)90303-2
The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying.
G. Strauss (1986)
10.1016/S0378-5173(98)00282-8
Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles
C. Bocca (1998)
10.3109/02652049809006847
Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
H. Heiati (1998)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/S0378-5173(98)00092-1
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
10.1016/0016-5085(80)90777-5
Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat: in vitro experiments with the porcine enzymes.
B. Borgström (1980)
10.1080/026520499289310
Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.
C. Freitas (1999)
10.1007/978-1-4899-2905-1_8
Physical Properties — Structural and Physical Characteristics
K. Larsson (1986)
10.1016/S0378-5173(98)00404-9
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
10.1136/adc.67.12.1475
Hazards of parenteral treatment: do particles count?
J. Puntis (1992)
10.1016/0005-2736(94)90003-5
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity.
V. Torchilin (1994)
10.1126/SCIENCE.2928794
Imaging crystals, polymers, and processes in water with the atomic force microscope.
B. Drake (1989)
Albumin microspheres for study of the reticuloendothelial system.
U. Scheffel (1972)
10.1016/0378-5173(93)90177-H
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/0378-5173(89)90329-3
Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use
M. Y. Levy (1989)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules
R. Cavalli (1998)
10.1016/S0378-5173(96)04782-5
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
Stabilization of liposomes by freeze-thaw- and lyophilization techniques : problems and opportunities
M. Ausborn (1992)
10.1021/bp990135c
Gaulin Homogenization: A Mechanistic Study
R. Lander (2000)
10.1016/0304-3991(92)90418-J
In situ investigations of single living cells infected by viruses.
W. Haeberle (1992)
10.1016/0304-4157(92)90038-C
Sterically stabilized liposomes.
M. Woodle (1992)
Fate and behavior of liposomes in vivo: a review of controlling factors.
J. H. Senior (1987)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1016/0378-5173(93)90315-7
In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulocytes
S. Rudt (1993)
10.1248/CPB.31.237
Influence of fatty acid composition on the properties and polymorphic transition of fatty suppository bases.
H. Yoshino (1983)
10.1016/0008-6215(94)00294-P
Imaging xanthan gum by atomic force microscopy
A. Kirby (1995)
10.3109/02652049409051118
Autoclaving of liposomes.
A. Lukyanov (1994)
10.1016/S0378-5173(97)04890-4
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
K. Westesen (1997)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1016/S0378-5173(97)00222-6
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN).
Schwarz (1997)
10.1200/JCO.1986.4.5.789
Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data.
J. Sculier (1986)
10.1016/S0378-5173(99)00049-6
Nanospheres of cyclosporin A: poor oral absorption in dogs.
J. Ford (1999)
10.1016/0378-5173(93)90313-5
Solid lipospheres of doxorubicin and idarubicin
R. Cavalli (1993)
HPMA copolymer-bound anticancer drugs: Mechanism of action on cellular and subcellular levels
J. Kopeček (1999)



This paper is referenced by
10.4236/JCDSA.2016.61007
Silver Nanoparticles in Cosmetics
S. Gajbhiye (2016)
10.2174/157340707783220301
Innovative Drug Delivery Systems for the Administration of Natural Compounds
D. Paolino (2007)
10.1023/B:PHAM.0000019291.36636.c1
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Sylvia A. Wissing (2004)
10.3797/scipharm.1105-09
Functions of Lipids for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs
B. K. Nanjwade (2011)
10.5772/26878
LNCaP Prostate Cancer Growth In Vivo: Oncostatic Effects of Melatonin as Compared to Hypoxia and Reoxygenation
L. Terraneo (2011)
Preparation Methods of Solid Lipid Nanoparticles for Hydrophilic Peptides and Proteins
Xu Qun-wei (2010)
A Novel Approch For Development And Charectrization Of Etoposide Loaded Solid Lipid Nanoparticles
Sompur C.K.A (2011)
Nanopartículas e suas aplicações em Ciências Farmacêuticas
N. Franco (2013)
10.1590/0104-6632.20170343S20150669
Fatty acids profile of chia oil-loaded lipid microparticles
M. F. Souza (2017)
10.2147/IJN.S133832
Physicochemical characterization of drug nanocarriers
Eloísa Berbel Manaia (2017)
10.4028/www.scientific.net/MSF.913.707
Easy Preparation of Bacterial Cellulose/Triamcinolone Acetonide Composites and their Inhibition for Fibroblasts
M. Jin (2018)
FORMULATION OPTIMIZATION BY BOX BEHNKEN STATISTICAL DESIGN AND CHARACTERIZATION OF SAQUINAVIR LOADED SLNS FOR BRAIN DELIVERY
Mudragada Shailaja Prakash V Diwan (2013)
10.3109/02652048.2013.788090
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
A. Beloqui (2014)
10.1002/9781118292327.CH6
Nano‐ and Microencapsulation of Phytochemicals
S. Lee (2014)
10.1016/J.CARBPOL.2012.01.051
Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
J. Varshosaz (2012)
10.1016/j.foodchem.2013.05.120
Formation of solid shell nanoparticles with liquid ω-3 fatty acid core.
Hanna Salminen (2013)
10.1208/s12249-018-1078-0
Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles
J. Silva (2018)
10.4103/2230-973X.138342
Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics
M. Yusuf (2014)
10.3109/03639045.2016.1171335
Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation
Carol Yousry (2016)
10.1080/10717540500315930
In Situ Evading of Phagocytic Uptake of Stealth Solid Lipid Nanoparticles by Mouse Peritoneal Macrophages
Y. Wang (2006)
10.9734/BJPR/2014/7055
Formulation and Characterization of Nystatinloaded Nanostructured Lipid Carriers for Topical Delivery against Cutaneous Candidiasis.
R. Khalil (2014)
10.1016/J.EJPB.2005.09.003
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
N. Pedersen (2006)
10.1016/j.colsurfb.2011.07.060
Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
Y. Kuo (2011)
10.1002/adhm.201200338
Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging.
K. H. Bae (2013)
10.1007/s00706-016-1753-3
Kinetic and thermodynamic studies of methotrexate adsorption on chitosan-modified magnetic multi-walled carbon nanotubes
Bahman Vasheghani Farahani (2016)
10.1186/1471-2466-12-38
Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats
A. Roulet (2012)
10.1016/J.POWTEC.2013.01.037
Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery
L. F. C. Silva (2013)
10.14356/KONA.2013015
100 Years of Vitamins: The Science of Formulation is the Key to Functionality
A. Teleki (2013)
10.1504/IJBET.2009.022913
Nanostructured Lipid Carriers and their application in drug delivery
S. Khurana (2009)
10.1691/PH.2009.8222
Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins.
H. Van de Ven (2009)
10.1186/s43094-020-00051-z
Zotepine loaded lipid nanoparticles for oral delivery: development, characterization, and in vivo pharmacokinetic studies
B. Nagaraj (2020)
Chapter 3 Solid Lipid Nanoparticles : Tuneable Anti-Cancer Gene / Drug Delivery Systems
Tranum Kaur (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar